Burnham & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Burnham & Co's LLY Position: Q3 2026 in Review
Burnham & Co reduced its Eli Lilly (LLY) stake by 4.2% in Q3 2026, selling an estimated $406K and leaving 7,773 shares worth $8.99M. The position accounts for 7.1% of the portfolio, ranked #1.
Burnham & Co first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.7M in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Burnham & Co held 7,773 shares of Eli Lilly worth $8.99M as of Q3 2026.
- Burnham & Co sold 344 Eli Lilly shares in Q3 2026, an estimated $406K.
- Eli Lilly made up 7.1% of Burnham & Co's portfolio in Q3 2026, its #1 holding.
- Burnham & Co first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
- Burnham & Co's Eli Lilly position peaked at $9.7M in Q2 2026.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Burnham & Co's 13F filing for Q3 2026, filed 12 Nov 2026.